TY - JOUR
T1 - 「泌尿器科領域における周術期感染予防ガイドライン」に関する多施設共同研究
AU - Wada, Koichiro
AU - Uehara, Shinya
AU - Kira, Shinichiro
AU - Matsumoto, Masahiro
AU - Sho, Takehiko
AU - Kurimura, Yuichiro
AU - Hashimoto, Jiro
AU - Uehara, Teruhisa
AU - Yamane, Takashi
AU - Kanamaru, Sojun
AU - Togo, Yoshikazu
AU - Taoka, Rikiya
AU - Takahashi, Akira
AU - Yamada, Yusuke
AU - Yokomizo, Akira
AU - Yasuda, Mitsuru
AU - Tanaka, Kazushi
AU - Hamasuna, Ryoichi
AU - Takahashi, Satoshi
AU - Hayami, Hiroshi
AU - Watanabe, Toyohiko
AU - Monden, Koichi
AU - Kiyota, Hiroshi
AU - Deguchi, Takashi
AU - Naito, Seiji
AU - Tsukamoto, Taiji
AU - Arakawa, Soichi
AU - Fujisawa, Masato
AU - Yamamoto, Shingo
AU - Kumon, Hiromi
AU - Matsumoto, Tetsuro
PY - 2013/5/20
Y1 - 2013/5/20
N2 - (Objective) The "Japanese guidelines for prevention of perioperative infections in urological field" was edited by the Japanese Urological Association in 2007. They are the first Japanese guidelines for antimicrobial prophylaxis specifically to prevent perioperative infections in the urological field. We report here the results of a multicenter prospective study conducted to examine the validity and usefulness of these guidelines. (Patients and methods) The subjects were 513 patients who had undergone urological surgeries between July and September 2008 at 10 nationwide university institutions in the Japanese Society of UTI Cooperative Study Group. These surgeries were transurethral resection of bladder (TURBT), transurethral resection of prostate (TURP), adrenalectomy, nephrectomy, nephroureterectomy, radical prostatectomy and total cystectomy. Analysis was performed on patient information, surgical procedures, types and durations of administration of prophylactic antibiotic agents, and the presence of surgical site infections (SSI) and remote infections (RI). (Results) Of 513 patients, 387 (75.4%) were administered prophylactic antibiotic agents according to the guidelines. In these patients, the incidences of SSI and RI were 5.9% and 4.1%, respectively. Multivariate analysis showed that significant factors for SSI were the surgical risk (according to the ASA physical status classification system), diabetes, and operation time, and that the only significant factor for RI was the operation time. (Conclusions) More large-scale study and evidences are necessary in order to demonstrate the validity and usefulness of these guidelines.
AB - (Objective) The "Japanese guidelines for prevention of perioperative infections in urological field" was edited by the Japanese Urological Association in 2007. They are the first Japanese guidelines for antimicrobial prophylaxis specifically to prevent perioperative infections in the urological field. We report here the results of a multicenter prospective study conducted to examine the validity and usefulness of these guidelines. (Patients and methods) The subjects were 513 patients who had undergone urological surgeries between July and September 2008 at 10 nationwide university institutions in the Japanese Society of UTI Cooperative Study Group. These surgeries were transurethral resection of bladder (TURBT), transurethral resection of prostate (TURP), adrenalectomy, nephrectomy, nephroureterectomy, radical prostatectomy and total cystectomy. Analysis was performed on patient information, surgical procedures, types and durations of administration of prophylactic antibiotic agents, and the presence of surgical site infections (SSI) and remote infections (RI). (Results) Of 513 patients, 387 (75.4%) were administered prophylactic antibiotic agents according to the guidelines. In these patients, the incidences of SSI and RI were 5.9% and 4.1%, respectively. Multivariate analysis showed that significant factors for SSI were the surgical risk (according to the ASA physical status classification system), diabetes, and operation time, and that the only significant factor for RI was the operation time. (Conclusions) More large-scale study and evidences are necessary in order to demonstrate the validity and usefulness of these guidelines.
KW - Perioperative infections
KW - Prophylactic antibiotic agent
KW - Urological surgery
UR - http://www.scopus.com/inward/record.url?scp=84879214170&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84879214170&partnerID=8YFLogxK
U2 - 10.5980/jpnjurol.104.505
DO - 10.5980/jpnjurol.104.505
M3 - Article
C2 - 23819362
AN - SCOPUS:84879214170
SN - 0021-5287
VL - 104
SP - 505
EP - 512
JO - Japanese Journal of Urology
JF - Japanese Journal of Urology
IS - 3
ER -